Introduction
Besides its hormonal effects, thyrotropin releasing hormone (TRH) induces several behavioral changes in rats. Marked increases in locomotor activity occur after administration of TRH and its analogs. This effect was hypothesized to be due to a stimulation of mesolimbic dopaminergic neurons (Miyamoto and Nagawa, 1977; Heal and Green, 1979) .
TRH has no effect on the reuptake of monoamines (Tuomisto and Mannist, 1973) or the concentration of dopamine (DA) sensitive adenylate cyclase (Green et al. 1976) . It was proposed that TRH and its analogs release DA from presynaptic terminals of dopaminergic neurons. Kerwin and Pycock (1979) demonstrated that TRH induced 3H-DA release from the n. accumbens which was preloaded with 3H-DA. It did not release 3H-DA from the caudate nucleus. Fukuda et al. (1979) 2) Effects of high K+ and MAP on DA efflux High K+ (25 mM) induced a release of 5 ng and 10 ng DA/mg protein/10 min from the nucleus accumbens and the striatum, respectively.
This stimulatory effect of K+ did not occur in Ca2+ deficient KR solution (Fig.3) .
A dose dependent increase in DA efflux was induced by MAP (1Q-1-10-3 M), i. e. 10-7 M increased the efflux 1. 4 times, 10-6 M increased it 3. 2 times, 10-5 M increased it 42 times, 10-4 M increased it 58 times and 10-3 M increased it 32 times.
3) Effects of TRH-T and DN-1417 on DA efflux DN-1417 (10-4 M) caused a significant The absence of Ca2+ in the superfusion medium caused a significant attenuation of the DN-1417 induced release of DA (Fig. 4) . In contrast, TRH-T (10-4 M) had no effect on release of endogenous DA from either the nucleus accumbens or the striatum in these experiments (Table  1) .
Discussion

1) Release experiments
To study the release of neurotransmitters from brain slices and synaptosomes, slices have usually been loaded with labelled compounds. The radio activity in the medium, quantified by a scintillation counter, is indicative of the amount of released neurotransmitter.
The problem with this method is that the release of radiolabelled compound from the tissue may be different from the release of the endogenous compound. After the development of HPLC for sample separation and ECD for detection of catecholamines in the picogram range (Kissinger et al. 1973) , endogenous DA and noradorenaline released from brain slices into a chamber could be detected (Plotsky et al. 1977; Hamlet et al. 1981) . In the present study, K+ evoked DA release and also basal DA efflux from slices of nucleus accumbens and striatum of rats could be detected.
The calibration curve for DA indicates that less than 500 pg of DA in 6 ml of KR solution could be quantified.
The basal efflux of DA was 600 pg/mg protein/10 min from the striatum and 400 pg/mg protein/ 10 min from the nucleus accumbens. Hamlet et al. (1981) observed the release of endogenous catecholamines from slices of rat hypothalamus using a superfusion system, but a basal efflux of DA could not be detected.
This discrepancy can be explained by the difference of DA concentration in the hypothalamus and the striatum. Bennet et al. (1981) reported that the basal efflux of DA from striatum was ten times greater than in the present results.
They measured released DA in the incubation medium, not in the super fusate. As small physical shocks to slices caused significant increases in DA efflux, the DA released during the initial incubation might be accumlated in the chamber. Therefore, with an incubation technique, small changes of DA efflux from slices of brain may be difficult to observe because of the large amount of DA which accumlates in the control sample. Also, the DA which accumlates in the incubation medium might influence the release of DA from nerve endings by acting at presynaptic autoreceptors.
For these reasons, the superfusion method should be more physiolosical than the incubation method.
High K+ (25 mM) KR solution increased the DA efflux in a Ca2+ dependent manner. Six hours after the superfusion began, the DA efflux from the slices was still facilitated with high K+ (data not shown). MAP caused a dose -dependent increase in DA efflux. These results suggest that the superf usion system was useful to investigate the dynamics of endogenous DA release from slices of rat striatum and nudeus accumbens even after several hours.
2) Effects of TRH-T and DN-1417 on DA efflux
The fact that superfusion with DN -1417, but not TRH -T caused a significant increase in A efflux confirms the previous reports that the analog is more potent and longer acting than TRH in CNS behavioral paradigms (Miyamoto et al. 1981) . It has been reported that TRH enhances 3H-DA efflux from slices of rat brain which are preloaded with 3H-DA (Kerwin and Pycock, 1979) . Recently, Sharp et al. (1982) , using an incubation technique, observed that TRH has a very weak DA releasing action on slices of septum and hypothalamus of the rat in the presence of bacitracin, an inhibitor of TRH degradation. On the other hand, no stimulant effect of TRH-T on DA efflux was observed in the present experiment.
This discrepancy can be explained by the chemical and/or enzymatic decomposition of TRH in the present study. Therefore, further studies of the effect of TRH on DA efflux in the presence of an inhibitor of TRH degradation are necessary.
The stimulant effect of DN -1417 on DA efflux was greater in the nucleus accumbens than in the striatum. Previous studies have indicated that TRH and its analogue (CG 3509) cause significant increases in DA efflux from the nucleus accumbens, but not from the striatum (Kerwin and Pycock, 1977; Heal and Green, 1979; Sharp et al. 1979) . Bilateral injection of TRH into the nucleus accumbens produced a locomotor stimulation, but unilateral injection of TRH into the caudate nucleus provoked no behavioral changes (Miyamoto and Nagawa, 1977) . Fukuda et al. (1982) reported that a high concentration of TRH-T (10-2M) caused a significant increase in 3H-DA efflux, even from the striatum. The present results agree with these reports. The facilitating effect of DN -1417 on DA efflux was Ca2+ dependent, suggesting that the mechanism of DN-1417 induduced DA release is different from mechanism of MAP. The stimulant effect of MAP on DA efflux was due to a carriermediated transport system, which is Ca2+ independent (Fisher et al, 1978) . Therefore, it is possible that DN-1417 modulates DA release from DA nerve endings through a receptor coupled mechanism. Acetylcholine or 7-aminobutyric acid is a candidate for the primary substance which is modulated by TRH leading to the facilitating of DA efflux (Narumi et al. 1979; Rastogi et al. 1979 
